Session Information
2010 Midyear Clinical Meeting
Click here to go to the previous page
Treatment Controversies in Pediatric Pharmacotherapy: RSV, Antiepileptic Agents, and Dexmedetomidine
Track:
Education Sessions (CE)
Program Code: 245-L04
Date: Tuesday, December 7, 2010
Time: 2:00 PM to 4:30 PM EST
Location:
Ballroom B, Level 3
PROGRAM CHAIR:
Elizabeth Farrington
- Given the description of specific premature infants or term infants with risk factors for the development of severe respiratory syncytial virus (RSV), develop a palivizumab regimen that reflects application of the best evidence and current guidelines.
- Upon reviewing the evidence for the use of dexmedetomidine for the sedation of the pediatric patient in the ICU setting and for procedural sedation, apply the information to specific patient cases.
- Upon reviewing the three new antiepileptic agents approved by the FDA in 2009, explain their role in the treatment of epilepsy syndromes found primarily in pediatric patients.
This session is a part of:
Handout Online
